// App-Quantinova.ai

e15141 : Capecitabine-oxaliplatin (CAPOX) prior to chemoradiotherapy (CRT) and surgery in magnetic resonance imaging (MRI)-defined poor-risk rectal carcinoma (PRRC): A center experience.

Researchers

Presenter

  • Isabel Busquier

Principal Investigators

  • Jorge Soler

  • Leticia De avila

  • Maria De Julian

  • Maria Arnal

  • Nuria Ruiz

  • Jorge Molina

  • Carlos Burriel

  • Francisco Garcia

  • Virginia Morillo

  • Ramon De Las Penas

Medical Centers

  • Oncology Service Hospital Provincial of Castellon, Castellon, Spain

  • Oncology Service Hospital Provincial of Castellon, Castellon, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Capecitabine + Oxaliplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved